Summary

26
Setting
27
The joint Médecins Sans Frontières/Ministry of Health multidrug-resistant tuberculosis 28 (MDR-TB) programme; Karakalpakstan, Uzbekistan.
29
Objective
30
Uzbekistan has high rates of MDR-TB. We aimed to understand patients ' and prescribers' 31 attitudes to TB drug prescription, regulation, and drug-taking behaviour.
32
Methods
33
Participants (12 patients, 12 practitioners) were recruited purposively. Data were gathered 34 qualitatively using field notes and in-depth interviews and analysed thematically. networks. Second, positive influences on treatment were reported through patients, 43 practitioners and peers working effectively together to deliver the correct information and 44 support, which acted to normalise TB, reduce stigma and prevent misuse of TB drugs.
45
Conclusion
46
Effective case finding, patient support and community education strategies are essential.
47
Introduction
50
Multidrug-resistant tuberculosis (MDR-TB) describes TB resistant to the two most powerful 51 first-line TB drugs: rifampicin and isoniazid. MDR-TB is an emerging global problem, 52 affecting an estimated 3.5% of new TB cases and 20.5% of retreatment cases. 1 Drug 53 resistance is fuelled by many factors, including the quality of TB medications, poor 54 adherence to treatment, ineffective treatment and retreatment regimens 2, 3 and poor 55 hospital infection control practices. In addition, direct access to arbitrary use of TB drugs for 56 patients through the private market has been implicated in treatment failure and 57 development of drug resistance in high-burden countries. 4 For instance, in Tbilisi, Georgia, 58 TB drugs, including second-line agents used to treat MDR-TB, were widely available without 59 prescription at pharmacies. 5 Strategies to ensure effective drug management and supply 60 form a major component of the World Health Organisation Stop TB Strategy. 6 
Methods
109
Research design
We used a flexible participatory technique in which data were gathered from patients and 111 practitioners using in-depth interviews guided by topic-led questions as well as field notes. 
Data analysis
169
From the moment data were generated during the interviews the 'thinking and theorising' 170 of data analysis began. 13 so that the 'tagging' of words, phrases or paragraphs emerged into codes, which were 176 constantly compared and refined revealing the experiences of the participants rather than 177 being externally imposed. 14 The first author sorted codes and categories by interconnected 178 themes or concepts 13 and discussed these with the second author. Codes emerged 179 inductively; themes and categories were drawn from respondents to make 'implicit belief 180 systems explicit in order to generate some theoretical insight'. 15 The decision to perform 181 manual rather than electronic coding was partly related to the relatively small sample size 182 and also to the value of interacting with the data in a way that promoted continuous 
Results
196
The response rate was 86%. Participant age ranged from 22 to 60 years, with equal numbers 197 of men and women. Table 1 describes the characteristics of participants. Knowledge about TB and treatment should be an important component of future drug 334 regulation strategies. 25 The effective dissemination of correct knowledge can catalyse 335 change. It is apparent that poor knowledge and a sense that cure is difficult or that 336 treatment can fail can lead to stigma and non-disclosure of infection. 26 Therefore, the 337 communication of correct knowledge and understanding between patients, between 338 patients and their doctors, and between doctors is essential for uptake and completion of 339 effective TB treatment. 27 .  A free, patient-centred TB treatment approach is equally important for effective regulation.
 The system of drug regulation for narcotic and psychotropic drugs in Uzbekistan should be adapted for TB drugs, especially for those that are vital for the treatment of drug-resistant TB.
 Effective case finding, community education and patient support strategies should be included in programming to diminish the problem of shame and the desire for patients to seek treatment elsewhere.
 Development of training and education programmes aimed at increasing clear guidance to general health practitioners: i.e. doctors, pharmacists and radiologists.
 Inclusion of peer support within national TB programme strategies to enhance shared experience of TB treatment and cure.
